You just read:

Sanofi and Regeneron Announce Publication of Positive Phase 2 Results for Lipid-Lowering PCSK9 Antibody in The Lancet

News provided by

Sanofi and Regeneron Pharmaceuticals, Inc.

26 May, 2012, 16:30 BST